Acusphere raises $20M from Cephalon
Published on Nov 04, 2008 in Business
Listing 1531-1560 of 2,882 episodes
Acusphere raises $20M from Cephalon
November 04, 2008
Life Sciences, deals, Biotech Ryan McBride wrote: Watertown, MA-based biotech firm Acusphere (NASDAQ:ACUS) reports it has received a $5 million ini... More
Life Sciences, deals, Biotech Ryan McBride wrote: Watertown, MA-based biotech firm Acusphere (NASDAQ:ACUS) reports it has received a $5 million initial fee and $15 million in loans from biotech company Cephalon (NASDAQ:CEPH), headquartered in Frazer, PA. The deal gives Cephalon an exclusive worldwide license to Acusphere’s injectable formulation of anti-inflammatory drug celecoxib, which is in preclinical development. Comments | Permalink | Share | E-mail Less
Original Permalink
Copyright: All rights reserved by creator
Tags: Boston, Biotech, deals, Boston briefs, Life Sciences, Acusphere, celecoxib, Cephalon
